Close Menu

NEW YORK – Kogene Biotech said last week that it has received regulatory approval in Korea for its novel coronavirus test. The test, called the 2019 Novel Coronavirus Real-time PCR Kit, has been granted Emergency Use Assessment and Listing (EUAL) in Korea.

Specifically, the Seoul, Korea-based company has been granted EUAL from the Korea Centers for Disease Control and the Korea Food and Drug Administration. It is also the first novel coronavirus test to be granted EUAL in Korea, according to the firm.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.